GL1X · GenesisL1 explorer

MolNFT v1 · #187771 · protein

Crystal structure of spaa-SLH/G109A in complex with 4,6-pyr-beta-D- mannac-(1->4)-beta-D-glcnacome

7SV5 · Surface (S-) layer glycoprotein: “Crystal structure of spaa-SLH/G109A in complex with 4,6-pyr-beta-D- mannac-(1->4)-beta-D-glcnacome”. X-ray diffraction, 1 ligand (D2Y), 3 pockets (best druggability 0.71). MolNFT v1 #187771 on…

PDB
7SV5
Type
protein
Length
329 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Surface (S-) layer glycoprotein
UniProt
C1JZ07
Ligands
D2Y
Pockets
3 · best druggability 0.71

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASurface (S-) layer glycoproteinprotein16542% helix, 5% strandC1JZ07
BSurface (S-) layer glycoproteinprotein16441% helix, 5% strandC1JZ07

Ligands and binding sites

  • D2Y · methyl 2-acetamido-4-O-{2-acetamido-4,6-O-[(1S)-1-carboxyethylidene]-2-deoxy-beta-D-mannopyranosyl}-2-deoxy-beta-D-glucopyranoside · ligand · 2 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17930.710.7766GOL, D2Y
21440.420.7518empty
3820.410.7914empty

Interfaces

1 interface between chains.

  • A–B · 495 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 7SV5 · Crystal structure of SpaA-SLH/G109A in complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.